Brooks Laboratories Limited (NSE:BROOKS)
India · Delayed Price · Currency is INR 66.38
+2.53 (3.96%)
Sep 11, 2026, 3:29 PM IST
Brooks Laboratories Market Cap
Brooks Laboratories has a market cap or net worth of 1.94 billion as of September 11, 2026. Its market cap has decreased by -56.59% in one year.
Market Cap
1.94B
Enterprise Value
1.95B
Revenue
831.87M
Ranking
n/a
PE Ratio
14.62
Stock Price
66.38
ChartMarket Cap Chart
Since September 5, 2011, Brooks Laboratories's market cap has increased from 105.21M to 1.94B, an increase of 1,739.19%. That is a compound annual growth rate of 21.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 1.94B | -18.03% |
| Dec 31, 2025 | 2.36B | -50.07% |
| Dec 31, 2024 | 4.73B | 25.45% |
| Dec 29, 2023 | 3.77B | 39.59% |
| Dec 30, 2022 | 2.70B | 8.92% |
| Dec 31, 2021 | 2.48B | 51.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anlon Healthcare | 10.40B |
| Amanta Healthcare | 7.68B |
| Bafna Pharmaceuticals | 7.13B |
| Valiant Laboratories | 6.95B |
| Nectar Lifesciences | 2.32B |
| Par Drugs and Chemicals | 1.73B |
| Alpa Laboratories | 1.30B |
| Balaxi Pharmaceuticals | 1.29B |